查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
免疫學全球市場規模調查和預測，按藥物類別按疾病適應症，按分銷渠道，按地區分析，2022-2029
市場調查報告書
商品編碼
1261226

免疫學全球市場規模調查和預測，按藥物類別按疾病適應症，按分銷渠道，按地區分析，2022-2029

Global Immunology Market Size study & Forecast, by Drug Class by Disease Indication, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球免疫學市場價值約為 979.3 億美元，預計在 2022-2029 年預測期內將以超過 8.5% 的健康增長率增長。

免疫學是醫學和生物學的研究領域，重點關注和研究免疫系統。 免疫系統以多種方式保護個體免受感染。 免疫藥物和物質通過增強或抑制免疫系統來改變免疫反應。 免疫藥物和物質用於治療和預防感染性疾病和自身免疫和免疫性疾病，如1型糖尿病、類風濕性關節炎和銀屑病關節炎。 全球市場的增長受到生物仿製藥需求激增、免疫疾病意識增強以及預防醫學需求增加等因素的推動。

此外，自身免疫性疾病發病率的增加已成為決定全球市場需求的重要因素。 美國國家幹細胞基金會的一項研究估計，在 80 多種自身免疫性疾病中，至少有一種會影響全球約 4% 的人。 例如，患者對這些藥物的需求不斷增加，導致各種市場進入者專注於開發新產品並將其推向市場。 例如，Lupin 在 2020 年 9 月宣布了一種仿製類風濕性關節炎藥物。 同樣，截至 2022 年 4 月，強生服務公司擁有約 20 個針對各種自身免疫性疾病適應症的管道項目，包括銀屑病關節炎、類風濕性關節炎和炎症性腸病，以及免疫學領域。因此，賽諾菲大約有 30 個管道項目. 這導致自身免疫性疾病的患病率增加，人們更加關注為其引入治療方法，從而推動了市場的增長。 此外，越來越多地引入新療法和越來越多的監管機構批准的產品也在可預見的幾年內提供了各種有利可圖的機會。 然而，高昂的治療成本和與產品相關的副作用阻礙了整個 2022-2029 年預測期內的市場增長。

全球免疫學市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於其先進的醫療基礎設施和不斷增加的研發投資，北美在銷售方面佔據了市場主導地位。 另一方面，由於自身免疫性疾病的增加、預防醫學需求的增加以及藥物批准的增加等因素，預計亞太地區在預測期內將以最高的複合年增長率增長。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品供應的深入分析。 .

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 免疫學市場，按地區劃分，2019-2029 年
    • 免疫學市場，按藥物類別，2019-2029 年
    • 免疫學市場，按疾病適應症分類，2019-2029 年
    • 免疫學市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球免疫學市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第 3 章全球免疫學市場動態

  • 免疫學市場影響分析 (2019-2029)
    • 市場驅動因素
      • 自身免疫性疾病的增加
      • 對生物仿製藥的需求激增
    • 市場挑戰
      • 昂貴的醫療費用
      • 與產品相關的不良事件
    • 市場機會
      • 更多地引入創新產品
      • 監管機構批准的產品數量增加

第四章全球免疫學市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 主要投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球免疫學市場：按藥物類別分類

  • 市場概況
  • 全球免疫學市場：按藥物類別、性能-潛力分析
  • 2019-2029 年按藥物類別劃分的免疫學全球市場估計和預測
  • 免疫學市場，按細分市場分析
    • 單克隆抗體
    • 免疫抑製劑
    • 融合蛋白
    • 其他

第 7 章全球免疫學市場：按疾病適應症分類

  • 市場概況
  • 全球免疫學市場：按適應症分類的表現 - 潛力分析
  • 2019-2029 年按疾病分類的全球免疫學市場估計和預測
  • 免疫學市場，按細分市場分析
    • 類風濕性關節炎
    • 銀屑病關節炎
    • 斑塊狀銀屑病
    • 強直性脊柱炎
    • 炎症性腸病
    • 其他

第 8 章全球免疫學市場：按分銷渠道

  • 市場概況
  • 全球免疫學市場：按分銷渠道、性能-潛力分析
  • 2019-2029 年按分銷渠道劃分的免疫學全球市場估計和預測
  • 免疫學市場，按細分市場分析
    • 醫院藥房
    • 零售藥房
    • 在線藥店

第 9 章全球免疫學市場：區域分析

  • 免疫學市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按藥物類別的估計和預測
      • 2019-2029 年按疾病和適應症分類的估計和預測
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲免疫學市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太免疫學市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲免疫學市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 艾伯維公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • Janssen Global Services, LLC
    • Eli Lilly and Company
    • Novartis AG
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Merck Sharp & Dohme Corp.
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Astellas Pharma Inc.

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Immunology is the field of medical and biological research that focuses and studies the immune system. The immune system protects individuals from infection in numerous ways. by enhancing or inhibiting the immune system, immunology medications and substances alter the immunological response. Immunology drugs or agents are used to treat or prevent infections as well as several autoimmune and immunological diseases such type 1 diabetes, rheumatoid arthritis, and psoriatic arthritis. The global market growth is primarily driven by the factors such as a surge in demand for biosimilars, growing awareness about immunological diseases, coupled with the increasing demand for preventive care.

In addition, the rise in incidences of autoimmune disorders is a key factor that is stipulating the market demand in the global market. A study by the National Stem Cell Foundation estimates that at least one of 80 or more autoimmune illnesses affects about 4% of people around the world. For instance, various market participants are focusing on creating and introducing new products to the market as a result of the growing demand for these medications among patients. For instance, Lupin introduced a generic rheumatoid arthritis medication in September 2020. Likewise, As of April 2022, there were approximately 20 pipeline projects from Johnson & Johnson Services, Inc. for a variety of autoimmune indications, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and others, and approximately 30 pipeline projects from Sanofi in the immunology segment. Thereby, the increasing prevalence of autoimmune disorders and growing emphasis on introducing its treatments is boosting the market growth. Moreover, the rising introduction of novel therapies, as well as the increasing product approvals by regulatory agencies are presenting various lucrative opportunities over the forecasting years. However, the high cost of treatment and adverse effects associated with the product are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Immunology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced healthcare infrastructure, along with growing investment on research and development activities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising occurrence of autoimmune conditions, surging demand for preventive care, and increasing drug approvals in the regional market space.

Major market players included in this report are:

  • AbbVie, Inc.
  • Janssen Global Services, LLC
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • F. Hoffmann-La Roche Ltd.
  • Amgen Inc.
  • Astellas Pharma Inc.

Recent Developments in the Market:

  • In June 2022, Eli Lilly and Company received the U.S. FDA approval for its OLUMIANT- a first-in-disease systemic treatment that is specially developed for adults with severe alopecia areata (AA), an autoimmune disorder.
  • In April 2022, AbbVie Inc. received the U.S. FDA approval for its RINVOQ to provide treatment to adult patients with active ankylosing spondylitis.
  • In March 2022, Pfizer Inc. announced that the company acquired Arena Pharmaceuticals, a company that primarily focuses on advancing innovative potential therapies to cure several immuno-inflammatory diseases. The objective of this acquisition is to expand Pfizer Inc. product portfolio.

Global Immunology Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Monoclonal Antibody
  • Immunosuppressants
  • Fusion Proteins
  • Others

By Disease Indication:

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
  • Inflammatory Bowel Disease
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Immunology Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Immunology Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Immunology Market, by Disease Indication, 2019-2029 (USD Billion)
    • 1.2.4. Immunology Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Immunology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Immunology Market Dynamics

  • 3.1. Immunology Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of autoimmune disorders
      • 3.1.1.2. Surge in demand for biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment
      • 3.1.2.2. Adverse effects associated with product
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Introduction of innovative products
      • 3.1.3.2. Increasing product approvals by regulatory agencies

Chapter 4. Global Immunology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Immunology Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Immunology Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Immunology Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Immunology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibody
    • 6.4.2. Immunosuppressants
    • 6.4.3. Fusion Proteins
    • 6.4.4. Others

Chapter 7. Global Immunology Market, by Disease Indication

  • 7.1. Market Snapshot
  • 7.2. Global Immunology Market by Disease Indication, Performance - Potential Analysis
  • 7.3. Global Immunology Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
  • 7.4. Immunology Market, Sub Segment Analysis
    • 7.4.1. Rheumatoid Arthritis
    • 7.4.2. Psoriatic Arthritis
    • 7.4.3. Plaque Psoriasis
    • 7.4.4. Ankylosing Spondylitis
    • 7.4.5. Inflammatory Bowel Disease
    • 7.4.6. Others

Chapter 8. Global Immunology Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Immunology Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Immunology Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Immunology Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Immunology Market, Regional Analysis

  • 9.1. Immunology Market, Regional Market Snapshot
  • 9.2. North America Immunology Market
    • 9.2.1. U.S. Immunology Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Immunology Market
  • 9.3. Europe Immunology Market Snapshot
    • 9.3.1. U.K. Immunology Market
    • 9.3.2. Germany Immunology Market
    • 9.3.3. France Immunology Market
    • 9.3.4. Spain Immunology Market
    • 9.3.5. Italy Immunology Market
    • 9.3.6. Rest of Europe Immunology Market
  • 9.4. Asia-Pacific Immunology Market Snapshot
    • 9.4.1. China Immunology Market
    • 9.4.2. India Immunology Market
    • 9.4.3. Japan Immunology Market
    • 9.4.4. Australia Immunology Market
    • 9.4.5. South Korea Immunology Market
    • 9.4.6. Rest of Asia Pacific Immunology Market
  • 9.5. Latin America Immunology Market Snapshot
    • 9.5.1. Brazil Immunology Market
    • 9.5.2. Mexico Immunology Market
    • 9.5.3. Rest of Latin America Immunology Market
  • 9.6. Rest of The World Immunology Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Janssen Global Services, LLC
    • 10.2.3. Eli Lilly and Company
    • 10.2.4. Novartis AG
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Bristol-Myers Squibb Company
    • 10.2.7. Merck Sharp & Dohme Corp.
    • 10.2.8. F. Hoffmann-La Roche Ltd.
    • 10.2.9. Amgen Inc.
    • 10.2.10. Astellas Pharma Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Immunology Market, report scope
  • TABLE 2. Global Immunology Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Immunology Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Immunology Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Immunology Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Immunology Market
  • TABLE 71. List of primary sources, used in the study of global Immunology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Immunology Market, research methodology
  • FIG 2. Global Immunology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Immunology Market, key trends 2021
  • FIG 5. Global Immunology Market, growth prospects 2022-2029
  • FIG 6. Global Immunology Market, porters 5 force model
  • FIG 7. Global Immunology Market, pest analysis
  • FIG 8. Global Immunology Market, value chain analysis
  • FIG 9. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Immunology Market, regional snapshot 2019 & 2029
  • FIG 15. North America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Immunology Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Immunology Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Immunology Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable